PARK INNOVARE

Blog

A perfect site for biotech and pharma companies!

Drug discovery has come a long way from crude extracts to pure chemicals, from guess work to a structural and targeted approach to finding new and better...

More details More details

Infrastructure and R&D solutions for biotech and pharmaceutical industries

The Swiss Light Source (SLS) at the Paul Scherrer Institute (PSI) and the free-electron laser (SwissFEL) provide beams of exceptional brightness and stability...

More details

Biotech and pharma at PARK INNOVAARE

PARK INNOVAARE provides the best possible operating conditions for biotech and pharmaceutical companies. This includes the availability of modern laboratories...

More details

Corporate Innovation Makeover: Excubation rules for the core business

This blog post is dedicated to the final three Excubation rules, and thus concludes our Corporate Innovation Makeover series. These three rules focus on...

More details

Corporate Innovation Makeover: Excubation rules 3 and 4

Building on the excubation conversation we started in this blog series, and having introduced first two rules of the approach, we dive here into the next...

More details

Unprecedented speed and success rate with delivering ligand-bound GPCR structures

Modern drug discovery greatly benefits from knowledge of how a drug interacts with its molecular drug target. Membrane protein drug targets represent a...

More details

How can KPI steer your innovation process?

PARK INNOVAARE works at the interface of technology-driven companies and public research, such as at the nearby Paul Scherrer Institute (PSI). In one of...

More details

Methodically secret: what should you consider with respect to your know-how and trade secrets?

It falls short of a full appreciation of innovation to consider only patentable inventions. Process innovation, for instance, is usually not patentable....

More details

Radio-diagnosis paves the way for better therapy

In March 2017, the Strategy Committee at the Paul Scherrer Institute (PSI) gave its green light for a joint initiative with PARK INNOVAARE to join in realizing...

More details

Crystallization at its best

The success of many R&D projects in the pharmaceutical, chemical or agro industries depends on the exact and complete knowledge of a sample. To deliver...

More details

Electron diffraction opens new possibilities for structure-based drug discovery

Modern pharmaceutical development is tailored to the chemical and physical characteristics of active organic compounds. The reason why the atomic structure...

More details

State-of-the-art bioinformatics for better drug discovery

The effect a drug has on the human body depends on how well its active substance find its way to the targeted cells in the body, and on the chemical reactions...

More details